BI
BioCorRx Inc.
BICX · OTC
$0.21 +4.98% (+$0.01)
1M -19.20%
Market Cap $5.57M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.31
46.9% upside
Current Price
$0.21
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BICX is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
14 /100
Expensive P/S 7.08x
P/E N/A
EV/FFO N/A
Growth
100 /100
Growing Rev. growth 55.06%
EPS growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Gross margin 70.93%
FCF margin 299.44%
Net margin 401.89%
Quality
64 /100
Average ROIC 92.69%
Asset turnover 0.41x
ROA 165.74%
Debt
0 /100
High Current ratio 0.07x
Int. coverage -4.19x
Debt/Equity N/A
Stability
19 /100
Unstable Beta 0.22x
Profitable years 0
Rev. volatility 5,990.58%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BICX
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Lourdes Felix
Employees
3
Headquarters
Anaheim
Upcoming events
17 NOV
Earnings
Upcoming earnings report